Literature DB >> 28753845

Variability of Sex Disparities in Cancer Incidence over 30 Years: The Striking Case of Kidney Cancer.

Ghislaine Scelo1, Peng Li2, Estelle Chanudet2, David C Muller3.   

Abstract

It is well established that men are at higher risk of most non-sex-specific cancers than women, but there has been surprisingly little research investigating these differences. This is possibly because differences in exposure to established risk factors and hypothesised protection by female sex hormones are thought to account for the totality of the sex differences. These explanations remain somewhat speculative, as the magnitude of the sex ratio in cancer incidence has not been systematically studied, with no quantitative estimate of the variability of the sex ratio across countries, age groups, and periods of diagnosis. We analysed worldwide cancer incidence data for the years 1978-2007 in terms of sex disparities, and explicitly quantified the variability in sex disparities by age, year, and geographical region. Our analysis highlights several cancer types for which suspected and commonly accepted factors are unlikely to fully explain the observed sex disparity. In particular, kidney cancer showed a 2:1 male/female case incidence ratio that was constant by age, year, and region, suggesting that factors other than sociocultural habits and health behaviours are responsible for this sex disparity. PATIENT
SUMMARY: We quantified the difference in the incidence of various cancer types between men and women across the world over 30 years. While the trends for some cancers such as lung cancer are clearly correlated with known variations in lifestyle habits, we found that the sex disparity observed for others such as kidney cancer is unlikely to be explained by known risk factors.
Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Incidence rates; Sex disparities

Mesh:

Year:  2017        PMID: 28753845     DOI: 10.1016/j.euf.2017.01.006

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  16 in total

1.  Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies.

Authors:  Rebecca E Graff; Alejandro Sanchez; Deirdre K Tobias; Dayron Rodríguez; Glen W Barrisford; Michael L Blute; Yanping Li; Qi Sun; Mark A Preston; Kathryn M Wilson; Eunyoung Cho
Journal:  Diabetes Care       Date:  2018-04-20       Impact factor: 19.112

Review 2.  The spectrum of sex differences in cancer.

Authors:  Joshua B Rubin
Journal:  Trends Cancer       Date:  2022-02-18

3.  Kidney cancer trends and risk factors in Lebanon: a 12-year epidemiological study.

Authors:  Elise Assouad; Said El Hage; Steven Safi; Antonio El Kareh; Elie Mokled; Pascale Salameh
Journal:  Cancer Causes Control       Date:  2021-11-28       Impact factor: 2.506

4.  Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis.

Authors:  Wurong Du; Kaibo Guo; Huimin Jin; Leitao Sun; Shanming Ruan; Qiaoling Song
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 5.  Sexual dimorphism in solid and hematological malignancies.

Authors:  Isabel Ben-Batalla; María Elena Vargas-Delgado; Lara Meier; Sonja Loges
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

6.  Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.

Authors:  Spyros Kolovos; Guido Nador; Bhuvan Kishore; Matthew Streetly; Neil K Rabin; Andrew D Chantry; Kwee Yong; John Ashcroft; Stella Bowcock; Mark T Drayson; Karthik Ramasamy; Daniel Prieto-Alhambra; Cyrus Cooper; M Kassim Javaid; Rafael Pinedo-Villanueva
Journal:  J Bone Oncol       Date:  2019-06-07       Impact factor: 4.072

7.  The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer.

Authors:  Giovanni Minervini; Maria Pennuto; Silvio C E Tosatto
Journal:  Open Biol       Date:  2020-07-01       Impact factor: 6.411

8.  Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma.

Authors:  Ruhina S Laskar; Peng Li; Szilvia Ecsedi; Behnoush Abedi-Ardekani; Geoffroy Durand; Nivonirina Robinot; Jean-Noël Hubert; Vladimir Janout; David Zaridze; Anush Mukeria; Dana Mates; Ivana Holcatova; Lenka Foretova; Beata Swiatkowska; Zoran Dzamic; Sasa Milosavljevic; Robert Olaso; Anne Boland; Jean-François Deleuze; David C Muller; James D McKay; Paul Brennan; Florence Le Calvez-Kelm; Ghislaine Scelo; Estelle Chanudet
Journal:  Hum Mol Genet       Date:  2021-04-27       Impact factor: 6.150

Review 9.  Gender-Related Approach to Kidney Cancer Management: Moving Forward.

Authors:  Mariangela Mancini; Marialaura Righetto; Giovannella Baggio
Journal:  Int J Mol Sci       Date:  2020-05-10       Impact factor: 5.923

Review 10.  Epidemiology and Risk Factors for Kidney Cancer.

Authors:  Ghislaine Scelo; Tricia L Larose
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.